Myriad Genetics Inc. | Ownership
Companies that own Myriad Genetics Inc.
BlackRock Fund Advisors
10,281,505
14.5%
667,070
0.03%
06/30/2018
Baillie Gifford & Co.
9,455,185
13.33%
-107,778
0.28%
06/30/2018
The Vanguard Group, Inc.
8,160,384
11.51%
458,845
0.01%
06/30/2018
D. E. Shaw & Co. LP
4,050,733
5.71%
-132,682
0.32%
06/30/2018
SSgA Funds Management, Inc.
3,128,672
4.41%
-507,997
0.01%
06/30/2018
Dimensional Fund Advisors LP
3,055,263
4.3%
-461,077
0.04%
06/30/2018
Thrivent Investment Management, Inc.
2,856,846
4.03%
8,042
0.43%
06/30/2018
Frontier Capital Management Co. LLC
2,376,935
3.35%
362,821
0.78%
06/30/2018
Acadian Asset Management LLC
2,327,720
3.28%
-53,062
0.28%
06/30/2018
Northern Trust Investments, Inc.
1,806,429
2.54%
52,541
0.02%
06/30/2018
| Address |
320 Wakara Way
Salt Lake City Utah 84108
United States
|
|
Employees
|
- |
| Website |
http://www.myriad.com |
| Updated |
07/08/2019 |
| Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic test. It operates through Diagnostics and Other segments. The Diagnostics segment engages in the provision of testing and collaborative development of testing that is designed to asses a risk of developing a disease later in life of an individual. |
